237 results
8-K
EX-99.3
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
on research and development and litigation; Expectations regarding the reimbursement environment for the Company’s products; The Company’s long-term strategy
8-K
EX-99.1
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
.
Research and development expenses were $3 million for each of the three months ended March 31, 2024 and March 31, 2023.
Investigation, restatement … expenditures for research and development based on regulatory developments. The Company describes additional risks and uncertainties in the Risk Factors
8-K
EX-99.2
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
for expansion outside of the U.S.; The effectiveness of amniotic tissue as a therapy for any particular indication or condition; Expected spending on research … and development and litigation; Expectations regarding the reimbursement environment for the Company’s products; The Company’s long-term strategy
8-K
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
expenditures for research and development based on regulatory developments. The Company describes additional risks and uncertainties in the Risk Factors
8-K
EX-99
cuhibk6rqrm
27 Mar 24
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
8:24am
8-K
EX-99.1
w5wr2vtk8
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
8-K
jo35 fscvuz
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
8-K
EX-99.2
n2woeg1yoqf4n280mm0
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
8-K
EX-99.2
szoyw
13 Nov 23
MIMEDX to Participate in Upcoming Investor Conferences
8:14am
8-K
n1tpmz
13 Nov 23
MIMEDX to Participate in Upcoming Investor Conferences
8:14am
8-K
EX-99.2
neflgv4ab
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
EX-99.1
15p8ugvp
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
wofxux ddakey1xado3c
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
EX-99.2
t1qv7lgrbc
5 Sep 23
MIMEDX to Present at Upcoming Investor Conferences
8:38am